A COST-EFFECTIVENESS THRESHOLD BASED ON THE MARGINAL RETURNS OF CARDIOVASCULAR HOSPITAL SPENDING
Author(s)
van Baal P, Perry-Duxbury M, Bakx P, Versteegh M, van Doorslaer E, Brouwer W
Erasmus University Rotterdam, Rotterdam, The Netherlands
Presentation Documents
OBJECTIVES: Traditionally, threshold levels of cost-effectiveness have been derived from willingness-to-pay studies, indicating the consumption value of health (v-thresholds). However, it has been argued that v-thresholds need to be supplemented by so-called k-thresholds, which are based on the marginal returns to health care. The objective of this research is to estimate a k-threshold based on the marginal returns to cardiovascular disease (CVD) hospital care in the Netherlands. METHODS: To estimate a k-threshold for hospital care on CVD we proceed in two steps: First, we estimate the impact of hospital spending on mortality using a Bayesian regression-modelling framework, using data on CVD mortality and CVD hospital spending by age and gender for the period 1994-2010. Second, we use life tables in combination with quality of life data to convert these estimates into a k-threshold expressed in euros per QALY gained. RESULTS: Our base case estimate resulted in an estimate of 41,000 per QALY gained. In our sensitivity analyses, we illustrated how the incorporation of prior evidence into the estimation pushes estimates downwards. It also revealed the importance of including a lagged effect of spending on mortality. CONCLUSIONS: This is the first attempt at an empirical foundation for a k-threshold value for the Netherlands. This k-threshold may serve as a benchmark value for decision-making as well as for future research regarding k-thresholds.
Conference/Value in Health Info
2018-11, ISPOR Europe 2018, Barcelona, Spain
Value in Health, Vol. 21, S3 (October 2018)
Code
PCV126
Topic
Economic Evaluation, Epidemiology & Public Health, Health Policy & Regulatory
Topic Subcategory
Approval & Labeling, Cost/Cost of Illness/Resource Use Studies, Public Health
Disease
Cardiovascular Disorders